With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that ...

With another inflammatory bowel disease (IBD) approval in the bag for Tremfya, Johnson & Johnson continues to make good on ...

Employees at banking giant JPMorgan Chase claimed in a new class action suit that the company mismanaged their benefits, ...

Alvotech has developed a biosimilar of Humira called AVT02, the first-filed biosimilar drug equal in strength to Humira’s latest formulation, which AbbVie markets as a high-concentration, pain ...

At one point Humira (adalimumab ... around 18 months after they started collaborating on antibody-drug conjugates for cancer. AbbVie hopes for another lift to its fast-growing ovarian cancer ...

Talks between CMS and drugmaker Amgen authorized under the Inflation Reduction Act (IRA), former President Biden's signature ...

You'll need passive income to live well in retirement, especially with Social Security's uncertain future. The Office of ...

Enbrel was one of 10 drugs that were the first to be brought ... but the advent of biosimilars for adalimumab (Humira), a popular alternative for most etanercept indications, may produce ...

So, you want to invest in AbbVie (NYSE: ABBV) because it's a promising dividend-paying stock, and you also want to receive $1 ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options ...

Biomedical research impacts all of us. I became curious about how drugs work after my mom was diagnosed with rheumatoid arthritis when ...

Organon pleasantly surprised me with its financial results for Q4 2024. Read why I believe OGN is an attractive stock for ...